Home   ->   news   ->   Press Releases

Press Releases

2009

News Archives: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2009/12/22
WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing

2009/12/22
WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Co

2009/12/07
WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening

2009/11/30
WuXi PharmaTech Awarded in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Yea

2009/10/30
WuXi AppTec Receives 2009 Schering-Plough Excellence Award

2009/10/22
WuXi PharmaTech Appoints Dr. Hui Cai as Vice President of Business Development

2009/08/14
WuXi PharmaTech Selected as One of the Top Ten Employers for New College Graduates in Pharmaceutical

2009/07/23
WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology

2009/06/30
WuXi PharmaTech Receives Award from BASF

2009/06/26
WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise

2009/06/26
WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations

2009/06/22
WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynThe

2009/05/05
WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance

2009/05/05
WuXi AppTec Receives 2009 Lilly Global Supplier Award

2009/03/31
WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection

2009/03/24
WuXi AppTec Welcomes Three Senior Professionals

2009/03/17
Professor K. C. Nicolaou Speaks at WuXi AppTec

2009/02/17
WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO

2009/02/10
WuXi AppTec Successfully Holds Its 2009 Supplier Conference in Shanghai

2009/02/08
WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Con

2009/02/05
WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board

2009/01/12
St. Paul and Atlanta Laboratories of WuXi PharmaTech (NYSE:WX) Receive ISO/IEC 17025:2005 Accreditat